Ascendis Pharma A/SASNDNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+36.2%
5Y CAGR+109.5%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+36.2%/yr
vs +294.2%/yr prior
5Y CAGR
+109.5%/yr
Recent deceleration
Acceleration
-258.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
40.4x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $77.46M | +18.3% |
| 2024 | $65.50M | +48.7% |
| 2023 | $44.06M | +43.6% |
| 2022 | $30.68M | +684.5% |
| 2021 | $3.91M | +103.9% |
| 2020 | $1.92M | +57.1% |
| 2019 | $1.22M | +861.4% |
| 2018 | $127000.00 | +30.9% |
| 2017 | $97000.00 | +1840.0% |
| 2016 | $5000.00 | - |